General Cardiovascular Risk Profile for Use in Primary Care:  8491 Patients In The Framingham Heart Study  
  Risk Factors Select Pre-Treatment Values Here Risk Points Select Post-Treatment Values Here* Risk Points  
  Age (yrs)  
  Total Cholesterol in mg%  
  HDL Cholesterol in mg%  
  Systolic BP (if patient receiving BP meds)  
  Systolic BP (if patient not receiving BP meds)  
  Is Patient Currently Smoking?  
  Point Total   Benefits of treatment in this calculator are speculative,  
  10-year risk of developing coronary heart disease, stroke, peripheral artery disease or heart failure in %  
  Patient's Cardiovascular Age in Years. (Age of a pt with no CVD risk factors  who has this many points.)   and assume full reversibility of the effects of risk factors. - JC  
  D’Agostino RB; Vasan RS; Pencina MJ; Wolf PA; Cobain M; Massaro JM; Kannel WB. General Cardiovascular Risk Profile for Use in Primary Care. The Framingham Heart Study. Circulation. 2008;117:743-753.  
  Data Source:The Framingham Heart Study (FHS). Period: 1967 onward. Risk categories: 0-6% Low, 6-20% Med, greater than 20% High.  
  Comment: This study is the product of the Framingham Heart Study, which has been ongoing since 1948. The data that was used  
  in the current calculator design was gathered from 3 cohorts (1967-1971, 1971-1975 and 1984-1987). This included 4522 women  
  and 3969 men, none of whom had evidence of cardiovascular disease at the time of entry into the study. The average age of these  
  subjects was 49 years (range 31 to 74 years) and the patients were followed for 12 years. This gives a total group experience  
  of about 100,000 patient-years of observation. Systolic blood pressure was measured twice at each visit. Cigarette smoking was determined  
  by pt. report. Diabetes = fasting glucose exceeding 126 or 140 mg%. BMI, trigylcerides, LDL, and diastolic BP did not improve the model.  
  *Web calculator design and HTML transfer by Dr. John Coyle, 2008. Post-treatment benefits are speculative, not proposed by FHS.